Zimmer Biomet Receives FDA Warning Letter

Zimmer Biomet (ZBH) received an FDA Warning Letter on August 24 related to observed non-conformities with current good manufacturing practice requirements at ZBH’s North Campus facility in Warsaw, Indiana.

This Warning Letter is the latest in a series of regulatory issues with ZBH’s legacy Biomet plant. The quality violations cited were found...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0